Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CEPH International is a specialized contract research organization (CRO) based in Seoul, South Korea, focusing on early-phase clinical trials and bioequivalence studies. Established in 2005, the company provides integrated services including Phase I clinical trial management, bioanalytical testing, and pharmacokinetic/pharmacodynamic (PK/PD) modeling. CEPH International operates its own clinical pharmacology center and maintains a strong track record of regulatory compliance with the South Korean Ministry of Food and Drug Safety (MFDS). The organization serves as a key partner for pharmaceutical companies seeking to conduct cost-effective and high-quality clinical evaluations for both generic and novel therapeutic candidates. Their expertise extends to biosimilar development and complex generic formulations, supporting the global expansion of the Korean pharmaceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ceph International.